TRAIL combinations: The new 'trail' for cancer therapy (Review).
about
sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatmentProgrammed cell death in aging.Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death.hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model.Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive systemCombination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer.Anti-cancer activity of ZnO chips by sustained zinc ion release.Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy.Inducing cell death in Glioblastoma.Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: First evidence in preclinical hepatocellular carcinoma.Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells.ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4.
P2860
Q33674412-4671E1C2-3706-4608-8FA6-325D3B8007FEQ35779447-C04FDF10-BB81-4E77-A615-227CCF14C2FBQ36125103-48BC2713-9A1D-4665-9E0E-2A04AE75A312Q36681641-A6CD0C34-55B8-42DA-902A-B86FB9FF698DQ36879787-D3FAB8EB-410A-4A26-92A4-EE15FFBCCDE5Q37027584-53A6F1F8-C6A3-4E56-854C-64E925C85A0EQ39029301-53F60C4A-771D-48BC-9D9C-7A332070EAAEQ41239989-95439A86-5A9D-4B45-9B89-5ED61DDCE901Q41679502-A447FEA9-7816-4762-9E52-B88391811691Q42094991-13B6293E-9CAF-4170-B404-983DA31B13FCQ45750661-FB99D27A-9B20-4841-A631-857A28C54E2AQ45872155-E3FD7DC2-D316-4962-8786-E79F05EB2B44Q47129762-32D5C125-98D9-4755-9A74-9F9C25F91135Q50000685-531A28C7-177C-4245-8DC5-DFA8B20042A1Q52655195-FE85BB42-0AE4-4FC1-8FBE-3B7B00AC0FECQ55022368-C8CEB782-A20E-4965-9E40-93D11110815F
P2860
TRAIL combinations: The new 'trail' for cancer therapy (Review).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TRAIL combinations: The new 'trail' for cancer therapy (Review).
@en
TRAIL combinations: The new 'trail' for cancer therapy
@nl
type
label
TRAIL combinations: The new 'trail' for cancer therapy (Review).
@en
TRAIL combinations: The new 'trail' for cancer therapy
@nl
prefLabel
TRAIL combinations: The new 'trail' for cancer therapy (Review).
@en
TRAIL combinations: The new 'trail' for cancer therapy
@nl
P2860
P356
P1433
P1476
TRAIL combinations: The new 'trail' for cancer therapy (Review).
@en
P2093
Asmaa Reda
P2860
P304
P356
10.3892/OL.2014.1922
P577
2014-02-27T00:00:00Z